What precautions should be taken for a neonate suspected of congenital cytomegalovirus (CMV) or congenital toxoplasmosis?

Precautions for Neonates Suspected with Congenital CMV/Toxoplasmosis

For neonates suspected of congenital CMV or toxoplasmosis, immediately initiate comprehensive diagnostic evaluation within the first 21 days of life for CMV (via urine or saliva PCR) and begin treatment for suspected toxoplasmosis while awaiting serologic confirmation, as early intervention directly impacts long-term neurodevelopmental outcomes and hearing preservation.

Immediate Diagnostic Workup

For Suspected Congenital CMV:

• Test within 21 days of life using urine or saliva PCR - this is the critical window for confirming congenital infection 1, 2
• Obtain dried blood spot (DBS) sample and ensure state newborn screening program stores it for years, as retrospective diagnosis is only possible using samples collected in first 3 weeks 3
• Note: DBS PCR has ~80% sensitivity, so negative results don't completely rule out infection 3

For Suspected Congenital Toxoplasmosis:

The clinical evaluation must include 4:

• Detailed physical and neurologic examination
• Ophthalmologic examination by a retinal specialist (chorioretinal lesions may appear late - 75% detected after 7 months, 50% after 3 years) 4
• Brainstem auditory evoked responses
• Head CT or ultrasonography
• Abdominal ultrasonography
• Neonatal blood testing for Toxoplasma IgM, IgA, and IgG antibodies

Treatment Initiation

For Suspected Congenital Toxoplasmosis:

Begin 12-month treatment immediately for suspected cases 4:

1. Pyrimethamine:

   • Days 1-2: 2 mg/kg/day orally divided twice daily
   • Days 3-60 (or to 6 months if symptomatic): 1 mg/kg/day orally daily
   • After 2 months: 1 mg/kg/day orally 3 times per week

2. Sulfadiazine: 100 mg/kg/day orally divided twice daily

3. Folinic acid (leucovorin): 10 mg three times per week

4. Add corticosteroids if severe chorioretinitis or CSF protein ≥1 g/dL (start 72 hours after anti-Toxoplasma therapy) 4

For Confirmed Symptomatic Congenital CMV:

• Valganciclovir or ganciclovir reduces hearing loss in 5 of 6 babies and improves neurodevelopmental outcomes 1
• 6-month course superior to 6-week course for developmental outcomes 3

Serial Monitoring Protocol

If Congenital Toxoplasmosis Cannot Be Confirmed or Ruled Out:

• Serial IgG antibody titers every 4-6 weeks until complete disappearance of maternal antibodies 4
• If antibodies persist beyond 12 months = confirmed infection (gold standard) 4
• If subsequent testing confirms infection, initiate full 12-month treatment regimen

Long-term Follow-up for Confirmed Cases:

Toxoplasmosis 4:

• Every 3 months: Clinical, neurologic, ophthalmologic, and serologic testing for first 2 years
• Every 6 months during third year
• Annually thereafter indefinitely (chorioretinal lesions can appear years later)

CMV 3:

• Minimum follow-up to 2 years of age or later depending on disease status
• Prospective hearing monitoring at regular intervals
• Report new hearing concerns immediately without waiting for scheduled visits
• High risk for progressive or late-onset vestibular dysfunction requiring balance assessment

Critical Pitfalls to Avoid

1. Do NOT defer treatment in U.S. neonates with suspected toxoplasmosis unless ALL criteria met: maternal infection in first/second trimester, negative amniotic fluid PCR at ≥18 weeks, no laboratory evidence in newborn, and mother received antepartum treatment 4 - this rarely applies in U.S. practice

2. Do NOT miss the 21-day window for CMV testing - after this period, only retrospective DBS testing is possible with lower sensitivity 3, 1

3. Do NOT assume negative initial serology rules out toxoplasmosis - serial testing is mandatory as maternal IgG may mask early infection 4

4. Do NOT skip ophthalmologic follow-up even in asymptomatic cases - most chorioretinal lesions appear after 7 months of age 4

Multidisciplinary Referrals

Assemble care team immediately 3:

• Infectious disease specialist (primary coordinator for newborn period)
• Pediatric otolaryngology
• Audiology
• Ophthalmology (retinal specialist for toxoplasmosis)
• Speech-language pathology
• Developmental pediatrician, neurology, physical therapy as needed

Both infections cause progressive hearing loss and neurodevelopmental sequelae that may be subtle at birth, making early comprehensive evaluation and prolonged follow-up non-negotiable for optimizing outcomes.